Clinical outcome: it is only mentioned in two
studies of LCHM vs. HCLF formulae, with a trend
towards a reduction in infections and pressure
ulcers in the LCHM group in one study,25 and a
trend towards a reduced length of hospital stay
in the LCHM group in the other.2
In conclusion, LCHM formulae seem to improve
cardio-vascular risk factors in diabetic patients, but
fail (possibly due to the short duration of most
studies) to show clinical benefits